Latest filing published 13 Feb 2026 for BALCHEM CORP.
Not enough history yet: 0 closed purchases, at least 2 are needed.
At PROCTER & GAMBLE Co, Kathleen B. Fish appears under the title Chf Rsch, Dev & Innv Officer, with 65 of the 79 filings. The record lists 31 sales worth EUR 31,232,639, with a median of EUR 808,325, and a single purchase: EUR 48,234 at Origin Materials, Inc. (Director) on November 16, 2021, which is 3 percent of the open-market trades.
The three largest sales, all at Procter & Gamble, are dated November 10, 2020 (EUR 2,985,173), November 16, 2018 (EUR 2,450,413) and April 26, 2019 (EUR 2,299,667). Balchem Corp adds 6 filings as Director. The record also holds 23 grants, 21 option exercises and 3 filings of another kind.
The year 2018 stands out with 23 filings, ahead of 2020 (15) and 2016 (13). Since 2021 the record shows 1 to 3 filings a year. Only one falls in the last twelve months, with no purchase or sale. Publication comes a median of 2 days after the trade.
The count of trades by Fish within 30 days of colleagues at PROCTER & GAMBLE Co is 31, 26 and 25. All on the same side. Colleagues in order: Carolyn M. Tastad, David S. Taylor and Jon R. Moeller.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 79 declarations